1. Identification of the Specific Hematopoietic Stem Cell Populations Responsible for Failure to Hypomethylating Agents in Myelodysplastic Syndromes. (April 2017) Authors: Ganan-Gomez, I.; Alfonso, A.; Ogoti, Y.; Yang, H.; Montalban-Bravo, G.; Yu, A.C.; Silver, S.; Clise-Dwyer, K.; Garcia-Manero, G.; Colla, S. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Overall Health, Daily Functioning, and Quality of Life in Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. (February 2020) Authors: Sardh, E.; Gouya, L.; Rees, D.C.; Stein, P.; Stölzel, U.; Aguilera Peiro, P.; Bissell, D.M.; Bonkovsky, H.L.; Keel, S.; Parker, C.; Phillips, J.D.; Silver, S.; Windyga, J.; D'Avola, D.; Ross, G.; Stewart, P.; Ritchie, B.; Oh, J.; Harper, P.; Wang, J.D. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗